Real-World Prospective Study Tracks Skin and Systemic Gains Across Psoriasis Biologics
A Nature-published prospective study tracks cutaneous and systemic improvements across different biologic therapies in a real-world longitudinal psoriasis cohort.
Topic
Real World Evidence
Topic
Real World Evidence
Tildrakizumab Holds Its Effect for 52 Weeks in Japanese Psoriasis Patients
Tildrakizumab sustained its benefit over 52 weeks in Japanese psoriasis patients in real-world care, adding durability evidence f…
Real-World Risankizumab Durability in High-Impact Psoriasis
HCPLive features Tina Bhutani, MD, MAS, on real-world risankizumab durability in high-impact psoriasis. The expert segment addres…
48-Week Real-World Study Tracks Lebrikizumab After Biologic Switch
A 48-week real-world retrospective study on Springer Nature Link tracks lebrikizumab in atopic dermatitis patients who switched f…
Lebrikizumab's Real-World Results: Two Mexican AD Cases Reported
Two moderate-to-severe atopic dermatitis patients in Mexico improved on lebrikizumab in routine practice, per a Cureus case repor…
Palvella Brings Clinical and Claims Data to Dermatology Conference Stage
Palvella Therapeutics presented clinical and claims data at a dermatology conference, pairing trial results with real-world analy…
Real-world analysis: Dupixent outcomes consistent across skin tones
Dupilumab produced positive outcomes in patients with skin of color, according to a real-world study covered in Managed Healthcar…
Aptos Thread PRO Study Anchors Real-World Aesthetic Outcomes
Cureus publishes a patient-reported outcomes study of Aptos thread-centered treatment in real-world aesthetic practice, expanding…
Cureus Paper Tracks Patient-Reported Outcomes After Aptos Thread Procedures
A new Cureus paper puts patient-reported outcomes at the center of Aptos thread-lift evaluation, reporting results from routine a…
Organon to Present Real-World VTAMA Data at 2026 Fall Clinical
Organon will present a new real-world analysis of VTAMA® (tapinarof) cream, 1%, at the 2026 Fall Clinical Dermatology Conference,…